Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 18;9(8):2669.
doi: 10.3390/jcm9082669.

Oxidative Stress, Telomere Shortening, and Apoptosis Associated to Sarcopenia and Frailty in Patients with Multimorbidity

Affiliations

Oxidative Stress, Telomere Shortening, and Apoptosis Associated to Sarcopenia and Frailty in Patients with Multimorbidity

Máximo Bernabeu-Wittel et al. J Clin Med. .

Abstract

Background: The presence of oxidative stress, telomere shortening, and apoptosis in polypathological patients (PP) with sarcopenia and frailty remains unknown.

Methods: Multicentric prospective observational study in order to assess oxidative stress markers (catalase, glutathione reductase (GR), total antioxidant capacity to reactive oxygen species (TAC-ROS), and superoxide dismutase (SOD)), absolute telomere length (aTL), and apoptosis (DNA fragmentation) in peripheral blood samples of a hospital-based population of PP. Associations of these biomarkers to sarcopenia, frailty, functional status, and 12-month mortality were analyzed.

Results: Of the 444 recruited patients, 97 (21.8%), 278 (62.6%), and 80 (18%) were sarcopenic, frail, or both, respectively. Oxidative stress markers (lower TAC-ROS and higher SOD) were significantly enhanced and aTL significantly shortened in patients with sarcopenia, frailty or both syndromes. No evidence of apoptosis was detected in blood leukocytes of any of the patients. Both oxidative stress markers (GR, p = 0.04) and telomere shortening (p = 0.001) were associated to death risk and to less survival days.

Conclusions: Oxidative stress markers and telomere length were enhanced and shortened, respectively, in blood samples of polypathological patients with sarcopenia and/or frailty. Both were associated to decreased survival. They could be useful in the clinical practice to assess vulnerable populations with multimorbidity and of potential interest as therapeutic targets.

Keywords: apoptosis; frailty; multimorbidity; oxidative stress; polypathological patients; sarcopenia; telomere length.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Colombo F., García-Goñi M., Schwierz C. Addressing multimorbidity to improve healthcare and economic sustainability. J. Comorb. 2016;6:21–27. doi: 10.15256/joc.2016.6.74. - DOI - PMC - PubMed
    1. Yarnall A.J., Sayer A.A., Clegg A., Rockwood K., Parker S., Hindle J.V. New horizons in multimorbidity in older adults. Age Ageing. 2017;46:882–888. doi: 10.1093/ageing/afx150. - DOI - PMC - PubMed
    1. Puth M.T., Weckbecker K., Schmid M., Münster E. Prevalence of multimorbidity in Germany: Impact of age and educational level in a cross-sectional study on 19,294 adults. BMC Public Health. 2017;17:826. doi: 10.1186/s12889-017-4833-3. - DOI - PMC - PubMed
    1. Fabbri E., Zoli M., Gonzalez-Freire M., Salive M.E., Studenski S.A., Ferrucci L. Aging and multimorbidity: New tasks, priorities, and frontiers for integrated gerontological and clinical research. J. Am. Med. Dir. Assoc. 2015;16:640–647. doi: 10.1016/j.jamda.2015.03.013. - DOI - PMC - PubMed
    1. Von Haehling S., Morley J.E., Anker S.D. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J. Cachex Sarcopenia Muscle. 2010;1:129–133. doi: 10.1007/s13539-010-0014-2. - DOI - PMC - PubMed

LinkOut - more resources